Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
09/2005
09/07/2005CN1217677C Medicine for treating rheumatic heart disease
09/07/2005CN1217652C Cosmetic method of treating skin
09/06/2005US6939990 Derivatives of dicarboxylic acid having pharmaceutical properties
09/06/2005US6939891 Heterocyclic ureas, their preparation and their use as vanilloid receptor antagonists
09/06/2005US6939886 Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor Type-1 (PAI-1)
09/06/2005US6939885 Sulfur compounds such as 4-tert-Butyl-N-[4-chloro-2-(1-oxy-pyridine-4-carbonyl)-phenyl]-benzenesulfonamide, used as chemokine receptor antagonists, antiinflamatory agents or as immunology modulators
09/06/2005US6939876 Mixture of analgesic and addition reducting compound of a gamma-aminobutyric acid
09/06/2005US6939872 2-anilino-pyrimidine derivatives as cyclin dependent kinase inhibitors
09/06/2005US6939860 Composition and method for treatment of neoplastic diseases associated with elevated matrix metalloproteinase activities using catechin compounds
09/06/2005US6939568 Hydrated dressing containing metal microbiocide
09/06/2005US6939376 Drug-delivery endovascular stent and method for treating restenosis
09/06/2005CA2278025C Aqueous suspension for nasal administration
09/06/2005CA2193329C Water soluble rapamycin esters
09/01/2005WO2005080553A1 Cell-associated physiologically active substance and cell culture supplement
09/01/2005WO2005080385A1 Indanol derivative
09/01/2005WO2005080330A1 Heteroarylphenylurea derivative
09/01/2005WO2005080319A1 Hydrazino alcohol derivatives useful as inhibitors of copper-containing amine oxidases
09/01/2005WO2005079788A1 Amino alcohol compound
09/01/2005WO2005070133A3 2,6-disubstituted piperidines as modulators of chemokine receptor activity
09/01/2005WO2002083873A3 Enzymes
09/01/2005US20050192350 Aspirin-triggered lipoxins as modulators of diseases associated with polymorphoneutrophil inflammation; antiinflammatory agents
09/01/2005US20050192336 Treatment may include administration of a second active agent, including but not limited to, an anti-inflammatory agent, an immnunosuppressant, mycophenolate mofetil, a biologic agent, or a Cox-2 inhibitor
09/01/2005US20050192332 Pyrazolecarboxylic acid tricyclic derivatives, preparation and pharmaceutical compositions containing same
09/01/2005US20050192318 5-[4-Methylsulfonyloxy-2-(S)-(3,4-dichlorophenyl)butyl]-10-cyano-3-(R)-methyl-6-oxo-3,4,5,6-tetrahydro-2H-benzo[b][1,5]oxazocine as antidepressant
09/01/2005US20050192317 Novel diamines having a casr modulating activity
09/01/2005US20050192307 Benzimidazolone compounds
09/01/2005US20050192306 Pyrimidine derivatives as selective inhibitors of COX-2
09/01/2005US20050192280 Beta-amino acid derivatives-inhibitors of leukocyte adhesion mediated by VLA-4
09/01/2005US20050192238 Modulation of the expression of genes dependent on stat-1
09/01/2005US20050192208 Cardiovascular disorders; antiarrhythmia agents; sodium channel moderators ; potassium channel moderators; prevent fibrillation
09/01/2005US20050191650 Used to reduce body temperature, suppress appetite, and therapy or prophylaxis of congestive heart failure and various stress-related disorders
09/01/2005US20050191345 Temperature-sensitive liposomal formulation
09/01/2005US20050191334 Sustained release device for implantation in the vitreal chamber or the posterior segment of the eye releasing a corticosteroid for an extended period of time
09/01/2005US20050191300 Immunotherapy of autoimmune disorders using antibodies which target B-cells
09/01/2005US20050191288 Administering to patient before or simultaneously with surgery at least one heparinase enzyme, wherein heparinase enzyme decreases localized inflammatory response in the tissue of the patient
09/01/2005US20050191268 Polyphenol-and protein-containing extracts of winemaking residues, and methods of using the same
09/01/2005US20050191267 Mulberry extract; whitening effects for darkened skin through antityrosinase activity, antioxidant and anti-inflammatory properties
09/01/2005CA2557539A1 Indanol derivative
09/01/2005CA2556818A1 Methods to relief pain
09/01/2005CA2556350A1 Prodrugs of substituted amino heterobicycles which modulate the function of the vanilloid-1 receptor (vr1)
09/01/2005CA2554965A1 Antibodies specific for activated confirmation of lfa-1
09/01/2005CA2554894A1 Triazole compounds and their use as metabotropic glutamate receptor antagonists
09/01/2005CA2498644A1 Anti-inflammatory and analgesic heterocyclic amidines that inhibit nitrogen oxide (no) production
08/2005
08/31/2005EP1568699A1 1,3-dihydroimidazole fused-ring compound
08/31/2005EP1568697A1 1,3-benzothiazinone derivatives, process for producing the same and use thereof
08/31/2005EP1568692A1 (pyridin-4-yl)alkyl-amides as TNF-alpha production inhibitors
08/31/2005EP1567508A1 1,2,4-triazole derivative, method for preparing the same, and pharmaceutical composition containing the same
08/31/2005EP1567507A1 1,2,3- triazole amide derivatives as cytokine inhibitors
08/31/2005EP1567502A1 Substituted dihydrophenanthridinesul fonamides
08/31/2005EP1567486A2 Bis-aryl sulfonamides
08/31/2005EP1567160A2 Method of treatment of myocardial infarction
08/31/2005EP1567145A1 Analgesic uses of norketamine and ketamine/norketamine prodrugs
08/31/2005EP1567126A2 Concentrated liquid valdecoxib composition
08/31/2005EP1517914B1 9-alpha-substituted estratrienes as selectively active estrogen
08/31/2005EP1397359B1 1-biaryl-1,8-napthyridin-4-one phosphodiesterase-4 inhibitors
08/31/2005EP1390366B1 The citrate salt of 5,8,14,-triazatetracyclo(10.3.1.02,11.04,9)-hexadeca-2(11),3,5,7,9-pentaene
08/31/2005EP1278723B1 P-(sulfonyl)-aryl and -heteroaryl amines
08/31/2005EP1268445B1 4-amino-5-cyano-2-anilino-pyrimidine derivatives and their use as inhibitors of cell-cycle kinases
08/31/2005EP1182200B1 Tricyclic fused heterocycle compounds, process for preparing the same and use thereof
08/31/2005EP1169060B1 Sodium channel blocker compositions and the use thereof
08/31/2005EP1169032B1 Ketoprofen microgranules, method for preparing the same and pharmaceutical compositions
08/31/2005EP1163212B1 Amide derivatives
08/31/2005EP1163204B1 Lipoxin compounds and their use
08/31/2005EP1140809B1 New biphenyl and biphenyl-analogous compounds as integrin antagonists
08/31/2005EP1095020B1 2-aminopyridine erivatives, their use as medicines and pharmaceutical compositions containing them
08/31/2005EP1073634B1 Method for producing enantiomerically pure n-methyl-n- (1s)-1-phenyl- 2-((3s)- 3-hydroxypyrrolidine- 1-yl)ethyl]- 2,2-diphenyl acetamide
08/31/2005EP1070048B1 Calcilytic compounds
08/31/2005EP0996731B1 Retroviral nucleic material and nucleotide fragments, in particular associated with multiple sclerosis and/or rheumatoid arthritis, for diagnostic, prophylactic and therapeutic uses
08/31/2005EP0973819B1 Non-antigenic branched polymer conjugates
08/31/2005EP0786002B1 Intracellular isoform of the interleukin-1 receptor antagonist
08/31/2005EP0721335B1 Mycophenolate mofetil high dose oral suspensions
08/31/2005CN1662664A Ldl receptor-related proteins 1 and 2 and treatment of bone or cartilage conditions
08/31/2005CN1662663A DNA enzyme to inhibit plasminogen activator inhibitor-1
08/31/2005CN1662555A Chimeric antagonist ANTH1
08/31/2005CN1662537A Pyrazolo (1, 5-a) pyrimidine derivative and nad(p)h oxidase inhibitor containing the same
08/31/2005CN1662532A Tetrahydropyranyl cyclopentyl tetrahydropyridopyridine modulators of chemokine receptor activity
08/31/2005CN1662530A Azabicyclo-octane and nonane derivatives with DPP-IV inhibiting activity
08/31/2005CN1662529A Thiazole derivatives as phosphodiesterase IV inhibitors
08/31/2005CN1662522A Novel compounds, their use and preparation
08/31/2005CN1662514A Benzothiadiazepine derivatives, processes for their preparation and pharmaceutical compositions containing them
08/31/2005CN1662513A 2-thioxothiazole derivative, method for preparing the same, and pharmaceutical composition containing the same
08/31/2005CN1662511A Pharmaceutical salts of reboxetine
08/31/2005CN1662509A Pyrrolo-triazine aniline compounds useful as kinase inhibitors
08/31/2005CN1662508A Compounds, compositions and methods
08/31/2005CN1662506A Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor
08/31/2005CN1662504A 2, 5-disubstituted 3-mercaptopentanoic acid
08/31/2005CN1662502A Cyanoguanidine produgs
08/31/2005CN1662501A Cyanoguanidine prodrugs
08/31/2005CN1662497A Derivative of n-[phenyl(piperidin-2-yl)methyl]benzamide, the preparation method thereof and application of same in therapeutics
08/31/2005CN1662496A Cannabinoid receptor agonists
08/31/2005CN1662490A Nitrooxyderivatives of cyclooxygenase-2 inhibitors
08/31/2005CN1662248A Compositions against inflammatory processes
08/31/2005CN1662245A (20s) 1alpha-hydroxy-2alpha-methyl and 2beta-methyl-19-nor-vitamin D3 and their uses
08/31/2005CN1662244A Powdery respiratory tonic composition
08/31/2005CN1662242A Pharmaceutical compositions for the treatment of diseases related to neurotrophines
08/31/2005CN1662236A Inhibitors of histone deacetylase
08/31/2005CN1662226A Monocompartment osmotic controlled drug delivery system
08/31/2005CN1662223A Spherical pellet containing a water-soluble active ingredient
08/31/2005CN1662177A Appts. and method for shape aesthetics
08/31/2005CN1660911A Connective tissue growth factor fragments and methods and uses thereof
1 ... 645 646 647 648 649 650 651 652 653 654 655 656 657 658 659 660 661 662 663 664 665 ... 1272